A personal challenge, a meaningful challenge.

The cancer

Cancer remains among the leading causes of death worldwide. This scenario urges the translation of scientific research into clinical benefits to the patients.

The treatment

Effective therapies persist a challenge to be addressed. Our purpose is to improve the outcome of cancer patients by personalizing the drug delivery system.

Worldwide incidence

18 million cases in 2018. 1 in 6 results in death

Economic impact

Costs of cancer in 2010 was estimated at approximately US$ 1.16 trillion

Expected growth

Global oncology therapeutics is expected increase 10-13% over the next 5 years.

Global market

Oncology therapeutic medicines are expected to reach $200 billion by 2022

Our solution

A targeted delivery system

Cancer personalized molecules

Feasible to chemical, radiation and immunological therapies

Our personalized molecules are design to specifically identify cancer cells and thus deliver with precision therapeutic interventions. Our approach is based on the technology of aptamers, being efficient, scalable and cheaper than those of other therapeutic classes such as monoclonal antibodies and antibody-drug conjugates, as also cellular and gene therapies.


Business approach

Making science available

We work on the development and marketing of a new class of personalized therapies. Key elements of our strategy are the collaboration with universities, private companies and hospitals to accelerate the translation of our expertise into improvements on clinical outcomes for cancer patients.


Industrialize synthetic molecules to advance and scale our platform;

Intellectual property

Strengthen and expand our intellectual property to protect our platform;


Work in collaboration with universities and private companies to accelerate the development technology.


Erika Molina, Ph.D.


Emerson Moretto, M.Sc.


Our partners

Supporter and Investor

Interested in partnering with Bioptamers? Contact us

   We are scientists.
Driven by knowledge
“Curiosity has its own reason for existing.”
Albert Einstein
   We are makers.
Driven by a problem-solve vision
“Making is fundamental to what it means to be human.”
Mark Hatch
   We are entrepreneurs.
Driven by a problem-solve vision
“Making the impossible inevitable.”
Michael Finnigan

Contact Us

Bioptamers, Inc.
Delaware, USA
Send us mail

Or follow us on social platform

© 2023 Bioptamers